Network pharmacology unveils the active components and potential mechanism of traditional efficacy of Mugua

Mugua is a Chinese herbal medicine derived from the dried mature fruit of Chaenomeles speciosa (Sweet) Nakai. This study aimed to dissect the active ingredients and mechanism of Mugua. In the present study, the active components of Mugua were collected and screened through databases combined with UPLC-Q/TOF-MS based qualitative analysis and literature mining, and their potential disease targets were predicted. Then, a network relationship diagram of "component-target-disease-efficacy" was constructed. Moreover, the key active components and core targets were analyzed by molecular docking and in vitro anti-inflammatory assays. The traditional efficacy of Mugua mainly corresponded to 4 diseases, namely, rheumatoid arthritis, diarrhea, edema, and emesis. After screening and comparison, it was found that IL-1β, IL-6, TNF, and epidermal growth factor receptor (EGFR) were the shared inflammatory targets of the 4 diseases. Gene ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment results showed that these targets were involved mainly in inflammatory responses and inflammation-related pathways, such as rheumatoid arthritis pathway and TNF signaling pathway. Network topology analysis revealed that succinic acid, cinnamic acid, citric acid, caffeic acid, gallic acid, ursolic acid, malic acid, betulinic acid, and oleanolic acid were the key active components, while IL-1β, IL-6, TNF, and EGFR were the shared core targets of these 4 diseases. These results suggested that Mugua could exert traditional efficacy through multi-component and multi-target synergistic mechanisms. Molecular docking results showed that all key active ingredients could autonomously bind to the shared core targets, and the in vitro anti-inflammatory results further confirmed that all the key active components had good anti-inflammatory activities. The present study found that Mugua mainly intervened in the inflammatory response and pathways by acting on key active components and core targets to exert traditional efficacy, providing a theoretical basis for further in-depth research.

Authors

Institutions

Publication Details

Journal
Medicine
Published
2024-12-20
DOI
https://doi.org/10.1097/md.0000000000041028
Citations
1
Primary Topic
Natural product bioactivities and synthesis
Type
article
Field-Weighted Citation Impact
0.23

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Network pharmacology unveils the active components and potential mechanism of traditional efficacy of Mugua

Shi‐Jun Yue, WU Yong-gang
1 citations
Medicine
Natural product bioactivities and synthesis
0.23
article

Network pharmacology unveils the active components and potential mechanism of traditional efficacy of Mugua

Shi‐Jun Yue, WU Yong-gang
article en
1 citations

Abstract

Mugua is a Chinese herbal medicine derived from the dried mature fruit of Chaenomeles speciosa (Sweet) Nakai. This study aimed to dissect the active ingredients and mechanism of Mugua. In the present study, the active components of Mugua were collected and screened through databases combined with UPLC-Q/TOF-MS based qualitative analysis and literature mining, and their potential disease targets were predicted. Then, a network relationship diagram of "component-target-disease-efficacy" was constructed. Moreover, the key active components and core targets were analyzed by molecular docking and in vitro anti-inflammatory assays. The traditional efficacy of Mugua mainly corresponded to 4 diseases, namely, rheumatoid arthritis, diarrhea, edema, and emesis. After screening and comparison, it was found that IL-1β, IL-6, TNF, and epidermal growth factor receptor (EGFR) were the shared inflammatory targets of the 4 diseases. Gene ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment results showed that these targets were involved mainly in inflammatory responses and inflammation-related pathways, such as rheumatoid arthritis pathway and TNF signaling pathway. Network topology analysis revealed that succinic acid, cinnamic acid, citric acid, caffeic acid, gallic acid, ursolic acid, malic acid, betulinic acid, and oleanolic acid were the key active components, while IL-1β, IL-6, TNF, and EGFR were the shared core targets of these 4 diseases. These results suggested that Mugua could exert traditional efficacy through multi-component and multi-target synergistic mechanisms. Molecular docking results showed that all key active ingredients could autonomously bind to the shared core targets, and the in vitro anti-inflammatory results further confirmed that all the key active components had good anti-inflammatory activities. The present study found that Mugua mainly intervened in the inflammatory response and pathways by acting on key active components and core targets to exert traditional efficacy, providing a theoretical basis for further in-depth research.

MedicineVol. 103(51)
Hebei University of Chinese Medicine (CN), Shaanxi University of Chinese Medicine (CN)
Natural Science Foundation of Shaanxi Province, Shaanxi University of Chinese Medicine
Openalex Percentile: Top 40%
Natural product bioactivities and synthesis
0.23
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.